IPA appoints Samir Mehta president; Samina Hamied as Vice President, Health News, ET HealthWorld
Speaking on improving accessibility and innovation with this new role, Samir Mehta said: “COVID 19 has been a difficult time for the Indian pharmaceutical industry. However, the industry rose to the challenges and ensured a continuous supply of drugs to patients. The pandemic further highlighted the importance of collaboration, access to affordable medicines and innovation to meet the health needs of the country. The IPA will work with stakeholders to enhance accessibility of medicines and help create an ecosystem of innovation that will benefit patients.
Indian Pharmaceutical Alliance (IPA) represents 23 national research-based pharmaceutical companies. Collectively, API companies account for over 85% of private sector investment in pharmaceutical research and development.
Speaking of the new leadership role, Samina Hamied said, “I am delighted to receive this opportunity to play a pivotal role in shaping the healthcare ecosystem and unlocking important growth opportunities. I look forward to working collaboratively with all stakeholders in the industry to ensure sustainable, resilient and agile operations and make a positive difference in the lives of patients. “
